Altimmune, Inc. Liquidation Value
ALT
Other
Cash & Equivalents
$43.76M
As of 2025-12-31
Current Price: $2.89 (as of 2026-04-24)
Key Metrics
Cash Liquidation Value
Cash minus Total Obligations
Cash: $43.76M
Total Obligations: -$50.69M
$-6.92M
Per share: $-0.06
Period: 2025-12-31
Liquid Liquidation Value
Cash + AR minus Total Obligations
Cash: $43.76M
AR: $0
Total Obligations: -$50.69M
$-6.92M
Per share: $-0.06
Period: 2025-12-31
Operating Liquidation Value
Cash + AR + Inventory minus Total Obligations
Cash: $43.76M
AR: $0
Inventory: $0
Total Obligations: -$50.69M
$-6.92M
Per share: $-0.06
Period: 2025-12-31
Build your own liquidation scenario
Adjust asset discounts and liability assumptions to see how assumptions affect the numbers.
Liquidation Ladder
| Metric | Total | Per Share |
|---|---|---|
| Cash Liquidation Value | $-6.92M | $-0.06 |
| Liquid Liquidation Value | $-6.92M | $-0.06 |
| Operating Liquidation Value | $-6.92M | $-0.06 |
Key Components (as of 2025-12-31)
| Cash & Equivalents | $43.76M |
| Accounts Receivable | N/A |
| Inventory | N/A |
| Current Liabilities | $15.00M |
| Long-term Debt | $34.29M |
| Op. Lease Liability | $1.40M |
| Finance Lease | N/A |
| Shares Outstanding | 110.9M |
Explore all 164 XBRL tags and build your own scenario → Open Calculator
Historical
| Period | Cash | AR | Inventory | AP | Curr Liab | LT Debt | Op Lease | Fin Lease |
|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | $43.76M | N/A | N/A | $2.72M | $15.00M | $34.29M | $1.40M | N/A |
| 2025-09-30 | $61.24M | N/A | N/A | $4.80M | $12.61M | $14.45M | $1.46M | N/A |
| 2025-06-30 | $183.10M | N/A | N/A | $851,000 | $9.22M | $14.33M | $1.52M | N/A |
| 2025-03-31 | $49.10M | N/A | N/A | $1.08M | $9.80M | N/A | $1.59M | N/A |
| 2024-12-31 | $36.93M | N/A | N/A | $211,000 | $10.47M | N/A | $1.68M | N/A |
| 2024-09-30 | $31.47M | N/A | N/A | $1.13M | $8.64M | N/A | $1.77M | N/A |
| 2024-06-30 | $57.13M | N/A | N/A | $2.69M | $15.15M | N/A | $1.86M | N/A |
| 2024-03-31 | $78.98M | N/A | N/A | $3.76M | $11.33M | N/A | $552,000 | N/A |
▼ Community Notes